LenoMed Medical
1
1
0.14
- Areas of investment
Summary
LenoMed Medical is the famous Corporate Investor, which was founded in 2014. The main department of described Corporate Investor is located in the Shanghai. The company was established in Asia in China.
The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Legend Capital. In the next rounds fund is usually obtained by Tonghua Dongbao Pharmaceutical, Tasly Great Health Industry Fund, Legend Capital.
Among the most successful fund investment fields, there are Health Care, Medical Device. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight POCTech Corporation.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2014.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.14
- Investments by industry
- Health Care (1)
- Medical (1)
- Medical Device (1)
- Investments by region
-
- China (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| POCTech Corporation | 01 Dec 2014 | Health Care, Medical Device, Medical | Early Stage Venture | 0 | China, Zhejiang, Huzhou |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.